VEGF therapy: a timely retreat.
Alfranca
Arántzazu
A
D000818:Animals; D000229:Dependovirus / Q000235:genetics; D004318:Doxycycline / Q000008:administration & dosage; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007511:Ischemia / Q000628:therapy; D018919:Neovascularization, Physiologic / Q000187:drug effects; D011994:Recombinant Proteins / Q000235:genetics / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics* / Q000627:therapeutic use*
D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D004318:Doxycycline